Aktien Sensor

Universal Health Services Inc. saw its stock price decline by 6% after releasing Q1 2025 earnings that missed expectations, citing a slowdown in post-Covid care recovery.

Universal Health Services Inc. saw its stock price decline by 6% after releasing Q1 2025 earnings that missed expectations, citing a slowdown in post-Covid care recovery.

Cochlear solidifies its position as the most trustworthy healthcare company globally, with strong market performance and financial metrics supporting its reputation.

Sartorius AG’s stock price has experienced fluctuations amid global market trends, but its substantial market capitalization and continued demand for precision electronic equipment and components suggest a positive outlook.

Sartorius AG’s stock price has experienced fluctuations amid global market trends, but its substantial market capitalization and continued demand for precision electronic equipment and components suggest a positive outlook.

Merck & Co Inc’s stock value surged by nearly 3% as the company’s recent FDA approval of an RSV antibody and participation in a major healthcare conference boosted investor optimism.

Merck & Co Inc’s stock value surged by nearly 3% as the company’s recent FDA approval of an RSV antibody and participation in a major healthcare conference boosted investor optimism.

Gilead Sciences Inc.’s stock price declined by over 2% after the FDA placed a clinical hold on the company’s HIV treatment trials due to a safety signal.

Gilead Sciences Inc.’s stock price declined by over 2% after the FDA placed a clinical hold on the company’s HIV treatment trials due to a safety signal.

Argenx SE presents positive trial data for its treatment efgartigimod, showing significant improvement in patients with myositis and Sjogren’s disease.